Blog - Page 991 of 5754 - QualityStocks

MondayJul 11, 2022 12:06 pm

QualityStocksNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Completes Payment Agreements, Fully Owns Sapientia

Eat Well Group (CSE: EWG) (OTC: EWGFF), a publicly traded investment company, has made the final payment to complete all obligations for ownership of Sapientia Technology LLC. EWGFF’s acquisition of the company closed on July 31, 2021, under the agreement to issue 3,741,969 EWGFF common shares along and make cash payments totaling $6.52 million to the former shareholders of Sapientia. The first $1 million of that obligation was paid on July 31, 2021, with the remaining amount being paid in installments, with the last installment made on July 8, 2022. Sapientia has created and filed multiple foundational patents within the…

MondayJul 11, 2022 12:00 pm

Odyssey Health, Inc.’s (ODYY) Sports Advisory Board Enhancing Public Awareness and Understanding of Traumatic Brain Injuries

Odyssey’s Sports Advisory Board (“SAB”) was formed in 2021 to enhance public awareness of traumatic brain injuries and concussion The board’s members – Abby Wambach, Kurt Warner, and Brett Favre – have had storied careers in their respective sports and have expressed hope that scientists will examine their brains after their death to advance their understanding of head trauma Abby Wambach has committed her brain to research, hoping her efforts will bridge the gender gap in understanding sports concussions in women Sports concussions are worse for women, with female athletes being more likely to develop a sports-related concussion than their…

MondayJul 11, 2022 11:58 am

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Enters Agreement Putting Cargo Van Program ‘Front and Center for Last Mile Delivery Opportunities’

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced its entry into a binding agreement with DelPack Logistics LLC (“DPL”), an Amazon Delivery Service Partner, for DPL to purchase up to 600 Mullen Class 2 EV cargo vans over the next 18 months. The vans will be fully homologated for the United States and equipped with all airbags as required by U.S. standards and a cabin comfort package, including adjustable seats, cup holders, an infotainment system, and comfortable passenger seat. In addition, the EV cargo vans will carry a minimum of an 80 kilowatt per hour battery…

MondayJul 11, 2022 11:41 am

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Acquires DMT Study Expected to Accelerate Clinical Development Path of CYB004

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that, through its wholly-owned subsidiary Cybin IRL Limited, it has completed the acquisition of a phase 1 N,N-dimethyltryptamine (“DMT”) study from Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1). The DMT study, which is the largest to date, is expected to accelerate the clinical development path of Cybin’s proprietary deuterated DMT molecule for the potential treatment of anxiety disorders, CYB004, by approximately nine months. “With the closing of this transaction, we are well on our way to advancing CYB004 through phase 1…

MondayJul 11, 2022 11:19 am

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Names Former Amazon, Boeing Exec as CFO

Flora Growth’s (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, has announced a new chief financial officer. Former Amazon and Boeing official Elshad Garayev has accepted the new position and will be joining the FLTC team on the business day following the date on which the company files its mid-year financial results with the Securities and Exchange Commission. Garayev has more than two decades of financial leadership experience, and has worked at Amazon, Boeing, BP and RPK Capital. In his new role, he will focus on FLGTC growth initiatives as well as financial…

MondayJul 11, 2022 11:15 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Expands Patient Eligibility for Brain Cancer Drug Trial, Receives Approval from U.S. FDA for Protocol Amendment

Novel brain cancer drug developer CNS Pharmaceuticals, Inc. has received approval from the U.S. FDA for a Protocol Amendment that expands patient eligibility for participation in its potentially pivotal Phase 2 clinical trial for a novel drug candidate that targets the nearly 100 percent fatal cancer glioblastoma (“GBM”) CNS is developing the drug candidate Berubicin as an alternative to the standard-of-care chemotherapy agent, Lomustine, with the hope that Berubicin will prove itself at least as effective and potentially more so Berubicin has demonstrated the capacity to cross the blood-brain barrier in order to attack central nervous system tumors directly, which…

MondayJul 11, 2022 10:30 am

Flora Growth Corp.’s (NASDAQ: FLGC) Shareholders Vote in Favor of All Proposals Submitted for Approval; Elect Brandon Konigsberg to Board of Directors

Shareholders approve all proposals submitted at this year’s annual shareholders’ meeting, including board members Among the seven members of the Board of Directors elected, six were incumbents, making Brandon Konigsberg the newest addition to the Board Mr. Konigsberg will lend his years of experience, having held key leadership positions in various organizations in the country Luis Merchan, Flora Growth’s Chairman and CEO, noted that Mr. Konigsberg’s appointment would help the organization achieve rapid financial growth and maximize shareholder value Annual shareholders’ meetings are usually landmark moments of shareholder democracy, offering shareholders an opportunity to participate in the company’s decisions and…

MondayJul 11, 2022 9:45 am

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Expands Lightning Network Reach with 17 International Nodes Routing Over 72 BTC and 36,000 Transactions

LQwD currently has Lightning Network nodes in several countries, including Canada, France, Italy, Indonesia, Japan, England, Bahrain, South Africa, South Korea, Sweden, Singapore, Brazil, Germany, India, Ireland, Hong Kong, and the United States Arcane Research reported that since its launch three years ago, the Lightning Network has grown to a capacity of almost 3,000 BTC with over 17,000 international nodes and 73,700 unique payment channels LQwD’s proprietary platform as a service offering also serves as a Liquidity Service Provider for merchants and incorporates an easy-to-use API The company hopes to expand to 24 international nodes by the end of the…

MondayJul 11, 2022 9:00 am

Freight Technologies Inc. (NASDAQ: FRGT) Is ‘One to Watch’

Fr8Tech aims to revolutionize cross-border shipping by providing shippers flexibility, visibility and simplicity Through Fr8app, the company reduces human touch points and expedites load booking times Fr8Tech seeks to lessen the carbon footprint of the logistics industry by minimizing empty miles for transportation firms and reducing overall paper consumption The company’s established foothold in Mexico, the U.S.’s largest trade partner, is key to its current efforts to promote sustainable growth in the cross-border shipping industry U.S.-Mexico cross-border annual freight spending is estimated at $385 billion The company is led by a strong management team with decades of experience in transportation…

FridayJul 08, 2022 2:53 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (SILO) Bringing Hope, Possible Therapeutic to Alzheimer’s Patients

Silo Pharma (OTCQB: SILO) is committed to serving patients, families and caregivers worldwide struggling with Alzheimer’s Disease (“AD”). Last year, the company entered into a sponsored research agreement (“SRA”) with Columbia University to investigate and advance psychedelic therapeutics for AD. Silo Pharma CEO Eric Weisblum expressed encouragement on partnering with Columbia University and Dr. Christine Ann Denny, an associate professor of clinical neurobiology, saying: “To bring hope and possibly a therapeutic to patients suffering from Alzheimer’s Disease is an exciting proposition for Silo Pharma.” Alongside its work with Columbia University, Silo has partnered with Zylo Therapeutics to use Zylo’s Z-pod…

Site Search

Company Search